Clinical Evaluation of Approved and Investigational Contact Lenses
NCT ID: NCT02669095
Last Updated: 2017-06-09
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
150 participants
INTERVENTIONAL
2016-01-31
2016-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Clinical Evaluation of Approved Contact Lenses
NCT02699593
Clinical Evaluation of Two Approved Contact Lenses
NCT02759692
Evaluation of Approved and Investigational Contact Lenses
NCT03228212
Clinical Evaluation of Fitting Investigational Contact Lenses
NCT03150485
Evaluating Accommodative Responses of Soft Contact Lenses for Myopia Control
NCT03635528
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Arm 1 (Test Lens)
Subjects will be dispensed the Investigational Contact Lenses (Test) to be worn as daily wear.
Investigational Contact Lenses (Test)
Arm 2 (Control Lens)
Subjects will be dispensed the Marketed Contact Lenses (Control) to be worn as daily wear.
Marketed Contact Lenses (Control)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Investigational Contact Lenses (Test)
Marketed Contact Lenses (Control)
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* The subject must appear able and willing to adhere to the instructions set forth in this clinical protocol.
* The subject must be between 18 to 40 years of age at the time of consent.
* The subject's vertexed spherical equivalent distance refraction must be in the range of +8.00 to -12.00 in each eye.
* Subject wears habitual contact lenses a minimum of 4 days per week, eight hours per day.
* The subject must have best corrected visual acuity of 20/30 or better in each eye.
* The subject must be a habitual frequent replacement daily wear spherical silicone hydrogel soft contact lens wearer in both eyes.
* The subject must be able to wear contact lenses for a minimum of 8 hours each day during the study.
* The subject must have normal eyes (i.e., no ocular medications or infections of any type).
Exclusion Criteria
* Any ocular or systemic allergies or diseases that may interfere with contact lens wear.
* Any systemic disease, autoimmune disease, or use of medication, which may interfere with contact lens wear.
* Any known sensitive/allergic to Ingredients of OPTI-FREE® PureMoist® solution.
* Entropion, ectropion, extrusions, chalazia, recurrent styes, glaucoma, history of recurrent corneal erosions, aphakia, or moderate or above corneal distortion.
* Any previous, or planned, ocular or interocular surgery (e.g., radial keratotomy, photorefractive keratectomy (PRK), laser-assisted in situ keratomileusis (LASIK), etc.).
* Any grade 3 or greater slit lamp findings (e.g., edema, corneal neovascularization, corneal staining, tarsal abnormalities, conjunctival injection) on the FDA classification scale, any previous history or signs of a contact lens-related corneal inflammatory event (e.g., past peripheral ulcer or round peripheral scar), or any other ocular abnormality that may contraindicate contact lens wear.
* Any ocular infection.
* Any corneal distortion resulting from previous hard or rigid gas permeable contact lens wear.
* Participation in any contact lens or lens care product clinical trial within 7 days prior to study enrollment.
18 Years
40 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Johnson & Johnson Vision Care, Inc.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Golden Family Eyecare
Sarasota, Florida, United States
Eye Associates of Winter Park
Winter Park, Florida, United States
Pickens Family Eye Care
Pickens, South Carolina, United States
Total Eye Care PA
Memphis, Tennessee, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CR-5796
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.